Elizabeth M Swisher Selected Research

BRCA1 Protein

12/2019	BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance.
3/2013	53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
7/2009	Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
4/2008	Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth M Swisher Research Topics

Disease

59	Neoplasms (Cancer) 01/2022 - 03/2002
58	Carcinoma (Carcinomatosis) 01/2022 - 03/2007
45	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2002
13	Breast Neoplasms (Breast Cancer) 02/2020 - 05/2002
6	Fatigue 01/2022 - 07/2017
6	Ovarian Epithelial Carcinoma 10/2020 - 09/2005
5	Triple Negative Breast Neoplasms 01/2022 - 11/2013
4	Anemia 01/2022 - 11/2017
4	Disease Progression 01/2020 - 01/2017
4	Nausea 01/2020 - 11/2017
3	Asthenia 01/2021 - 11/2017
3	Thrombocytopenia (Thrombopenia) 01/2020 - 10/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2013 - 06/2006
2	Neutropenia 01/2022 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021 - 02/2008
2	Genomic Instability 01/2020 - 01/2018
2	Vomiting 01/2020 - 11/2017
2	Neoplasm Metastasis (Metastasis) 10/2017 - 01/2007
2	Carcinogenesis 11/2012 - 05/2002
2	Endometrial Hyperplasia 07/2012 - 07/2008
2	Ascites 05/2012 - 08/2009
1	Peritoneal Neoplasms 10/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Fallopian Tube Neoplasms 12/2021
1	Cicatrix (Scar) 01/2021

Drug/Important Bio-Agent (IBA)

36	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 04/2011
29	PlatinumIBA 01/2022 - 04/2008
20	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 05/2002
19	rucaparibIBA 12/2021 - 01/2017
15	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2007
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2005
10	veliparibIBA 01/2022 - 06/2015
10	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021 - 04/2015
8	olaparibIBA 01/2022 - 07/2017
7	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 04/2011
7	Cisplatin (Platino)FDA LinkGeneric 11/2013 - 06/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2016
4	niraparibIBA 09/2021 - 11/2016
4	Pharmaceutical PreparationsIBA 01/2021 - 12/2016
4	BRCA1 ProteinIBA 12/2019 - 04/2008
3	AlpelisibIBA 01/2022 - 01/2019
3	Poly Adenosine Diphosphate RiboseIBA 12/2021 - 08/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2007
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2019
3	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2017
3	Bevacizumab (Avastin)FDA Link 10/2019 - 01/2018
3	Circulating Tumor DNAIBA 01/2019 - 09/2005
3	MicroRNAs (MicroRNA)IBA 01/2018 - 07/2010
3	Platinum Compounds (Compounds, Platinum)IBA 01/2016 - 02/2008
3	Protein Isoforms (Isoforms)IBA 01/2016 - 09/2010
2	cediranib (AZD2171)IBA 01/2022 - 07/2017
2	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2019
2	CreatinineIBA 01/2021 - 01/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2017
2	pembrolizumabIBA 01/2020 - 08/2019
2	durvalumabIBA 01/2020 - 07/2017
2	Codon (Codons)IBA 01/2020 - 03/2007
2	Messenger RNA (mRNA)IBA 01/2016 - 03/2013
2	Tumor Suppressor p53-Binding Protein 1IBA 10/2013 - 03/2013
2	MutL Protein Homolog 1IBA 01/2013 - 07/2009
2	Progestins (Progestagens)IBA 07/2012 - 07/2008
2	Epithelial Cell Adhesion MoleculeIBA 07/2012 - 05/2012
2	BRCA2 ProteinIBA 08/2009 - 07/2009
2	Estrogens (Estrogen)FDA Link 01/2007 - 05/2002
1	TFXIBA 01/2022
1	venetoclaxIBA 12/2021
1	talazoparibIBA 12/2021
1	Topoisomerase InhibitorsIBA 12/2021
1	ipatasertibIBA 01/2021
1	SteroidsIBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	MK 2206IBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 10/2020
1	Vinca AlkaloidsIBA 10/2020
1	AnthracyclinesIBA 10/2020
1	Drug CombinationsIBA 10/2020
1	AntimetabolitesIBA 10/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020
1	navitoclaxIBA 10/2020
1	Coloring Agents (Dyes)IBA 05/2020
1	chemotactic factor inactivatorIBA 01/2020
1	Protein CIBA 01/2020
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 12/2019
1	Adenosine Diphosphate (ADP)IBA 12/2019
1	Peptides (Polypeptides)IBA 12/2019
1	ABT-767IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	prexasertibIBA 01/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018

Therapy/Procedure

29	Therapeutics 01/2022 - 03/2002
25	Drug Therapy (Chemotherapy) 01/2022 - 03/2007
5	Salpingo-oophorectomy 10/2022 - 06/2006
3	Ovariectomy (Oophorectomy) 02/2020 - 04/2002
1	Precision Medicine 10/2021
1	Traction 01/2020
1	Salpingectomy 01/2020
1	Blood Transfusion (Blood Transfusions) 01/2020
1	Induction Chemotherapy 12/2019